Inhibition of phosphatidylinositol-3-kinase synergizes with gemcitabine in low-passage tumor cell lines correlating with Bax translocation to the mitochondria
Authors:
- Carmen Blanco-AparicioCBCarmen Blanco-Aparicio
- Belen PequeñoBPBelen Pequeño
- Victoria MoneoVMVictoria Moneo
- Lourdes RomeroLRLourdes Romero
- Juan F. M. LealJLJuan F. M. Leal
- Juan VelascoJVJuan Velasco
- Jesús FominayaJFJesús Fominaya
- Amancio CarneroAmancio Carnero
- 1 October 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 16 (9) , 977-987
Abstract
Apoptotic pathways, including the phosphatidylinositol-3-kinase (PI3K)/AKT survival pathway, are altered in most cancer cells in relation to their normal counterparts and these differences may present an excellent therapeutic window. To gain insight into the relevance of the PI3K pathway as a target for drug discovery we generated tumor cell lines from different tumor samples that we maintained at low passage. The characterization of these cell lines indicates that all of them have constitutively activated the PI3K pathway through different mechanisms. All cell lines were differentially sensitive to the PI3K inhibitor LY294002. Our data also support previous work indicating that PI3K inhibition might help classical chemotherapeutic treatments such as gemcitabine and strengthen suboptimal doses that might be effective for these purposes in decreasing the risk of side-effects. Finally, the analysis of the molecular markers that might be implicated in the synergism between LY294002 and gemcitabine suggests that PI3K inhibition might aid chemotherapeutic treatment, leading to changes in the balance between anti- and pro-apoptotic molecules of the Bcl-2 family, Bcl-XL and Bax. These results facilitate the exploration of potential synergism between chemotherapeutic treatment and the search for others that can account for similar molecular mechanisms of cooperation.Keywords
This publication has 32 references indexed in Scilit:
- Membrane localization of all class I PI 3‐kinase isoforms suppresses c‐Myc‐induced apoptosis in Rat1 fibroblasts via AktJournal of Cellular Biochemistry, 2005
- AKT/Protein Kinase B Regulation of BCL Family Members during Oxysterol-induced ApoptosisJournal of Biological Chemistry, 2004
- Chemosensitivity linked to p73 functionCancer Cell, 2003
- Thrombopoietin Regulates Bcl-xL Gene Expression through Stat5 and Phosphatidylinositol 3-Kinase Activation PathwaysJournal of Biological Chemistry, 2002
- Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment.Endocrine-Related Cancer, 2001
- p53 from complexity to simplicity: mutant p53 stabilization, gain‐of‐function, and dominant‐negative effectThe FASEB Journal, 2000
- The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cellsOncogene, 1999
- Tumor suppressor p53 is a direct transcriptional activator of the human bax geneCell, 1995
- The activation of phosphatidylinositol 3-kinase by RasCurrent Biology, 1994
- Phosphatidylinositol-3-OH kinase direct target of RasNature, 1994